Transradial Intervention in Dialysis Patients Undergoing Percutaneous Coronary Intervention: A Japanese Nationwide Registry Study

Abstract Background Transradial intervention (TRI) for percutaneous coronary intervention (PCI) is used to reduce periprocedural complications. However, its effectiveness and safety for patients on dialysis are not well established. Aims We aimed to investigate the association of TRI with in-hospital complications in dialysis patients undergoing PCI. Methods We included 44,462 patients on dialysis who underwent PCI using Japanese nationwide PCI registry data (2019–2021) regardless of acute or chronic coronary syndrome. Patients were categorized based on access site: TRI, transfemoral intervention (TFI). Periprocedural access site bleeding complication requiring transfusion was the primary outcome and in-hospital death and other periprocedural complications were the secondary outcomes. Matched weighted analysis was performed for TRI and TFI. Results Here, 8,267 (18.6%) underwent TRI, 36,195 (81.4%) underwent TFI, . Patients who received TRI were older and had lower rates of comorbidities than those who received TFI. Access site bleeding rate and in-hospital death were significantly lower in the TRI group (0.1% versus 0.7%, P < 0.001; 1.8% versus 3.2%, P < 0.001, respectively). After adjustment, TRI was associated with a lower risk of access site bleeding (odds ratio [OR] [95% confidence interval (CI)]: 0.19 [0.099–0.38]; P < 0.001) and in-hospital death (OR [95% CI]: 0.79 [0.65–0.96]; P = 0.02). Other periprocedural complications between TRI and TFI were not significantly different. Conclusions In patients undergoing dialysis and PCI, TRI had a lower risk of access site bleeding and in-hospital death than TFI. This suggests that TRI may be safer for this patient population.